a 2025

Positive correlation between amyloid-β and connectivity in cerebral organoids of a patient suffering from Alzheimer´s disease

BÉBAROVÁ, Markéta; Andrijana ANGELOVSKI; Hana HŘÍBKOVÁ; Jiří SEDMÍK; Barbora LIŠČÁKOVÁ et al.

Základní údaje

Originální název

Positive correlation between amyloid-β and connectivity in cerebral organoids of a patient suffering from Alzheimer´s disease

Vydání

Czech Neuroscience 2025, 2025

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30103 Neurosciences

Utajení

není předmětem státního či obchodního tajemství

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/25:00142652

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

amyloid-β; Alzheimer's disease; excitability; cerebral organoid; multielectrode array

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 16. 3. 2026 14:54, Mgr. Tereza Miškechová

Anotace

V originále

Introduction: Accumulation of amyloid-β (Aβ) and hyperphosphorylated tau (p-tau) is a characteristic feature of Alzheimer's disease (AD), leading to cognitive decline. Hyperexcitability is often associated with prodromal AD stages. Several possible causes of AD hyperexcitability, including the accumulation of neurodegenerative markers, are considered, but the relationship has not been directly proved. Hence, we aimed to investigate this relationship in cerebral organoids of a patient suffering from familial AD and carrying a PSEN1 variant and an unrelated healthy control (WT). Methods: Spontaneous electrical activity of WT (n = 16/3) and AD (n = 15/3) cerebral organoids was recorded twice per week between the differentiation day (DD) 60 and 139 at 37 °C using the multielectrode array technique (MEA2100-Lite-System, 60MEA-200/30iR-Ti; sampling rate 25 kHz). After filtering (300–3000 Hz), following parameters were evaluated: (i.) spikes – spike frequency (above 0.1 Hz), spike amplitude (above -6.5SD of the noise), interspike interval coefficient of variation (ISIcv), number of active electrodes, global synchrony index (GSI); (ii.) bursts – intraburst spike number (above 5) and frequency, burst duration (above 100 ms), interburst interval (above 100 ms), burst frequency, number of active electrodes. Values at the 3-week peak of the activity were compared. Regarding NAPs, the content of p-tau and Aβ aggregate size (immunocytochemistry), and secreted Aβ42/Aβ40 (ELISA) were examined. Results: We observed significantly higher connectivity in AD cerebral organoids compared to WT ones: number of active electrodes in spike activity (AD 22.0 vs. WT 5.9, P < 0.001) and burst activity (AD 18.7 vs. WT 1.7, P < 0.001), spike amplitude (AD 25.2 vs. WT 24.1 V, P < 0.05), GSI (AD 0.40 vs. WT 0.34, P < 0.001), intraburst spike number (AD 10.6 vs. WT 6.8, P < 0.001) and frequency (AD 41.7 vs. WT 37.2 Hz, P < 0.001), and burst duration (AD 242 vs. WT 208.3 ms, P < 0.05). A positive correlation was observed between the secreted Aβ42/Aβ40 and the number of active electrodes as well as GSI in the spike activity (the Spearman´s correlation coefficient rs = 0.94, P < 0.05, and rs = 1.00, P < 0.01, respectively), and between Aβ aggregate size and GSI (rs = 0.94, P < 0.05). Conclusion: We demonstrated that Aβ42/Aβ40 and Aβ deposits positively correlated with neuronal connectivity during spontaneous electrical activity in early AD. In contrast, the detected p-tau deposits were limited, thus, their role in the development of altered neuronal excitability in early AD is unlikely.

Návaznosti

GA24-12028S, projekt VaV
Název: Atlas Alzheimerovy choroby: Mapování vývoje demence u cerebrálních organoidů pomocí single-cell transkriptomiky
Investor: Grantová agentura ČR, Atlas Alzheimerovy choroby: Mapování vývoje demence u cerebrálních organoidů pomocí single-cell transkriptomiky
LX22NPO5107, projekt VaV
Název: Národní ústav pro neurologický výzkum
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Národní ústav pro neurologický výzkum, 5.1 EXCELES
MUNI/A/1641/2024, interní kód MU
Název: Od buňky k pacientovi II
Investor: Masarykova univerzita, Od buňky k pacientovi II
NU22-04-00366, projekt VaV
Název: Role neurodegenerace v patogenezi, manifestaci a prognóze MTLE/HS - in vivo, ex vivo a in vitro perspektiva
Investor: Ministerstvo zdravotnictví ČR, Role neurodegenerace v patogenezi, manifestaci a prognóze MTLE/HS - in vivo, ex vivo a in vitro perspektiva, Podprogram 1 - standardní